Tirzepatide is an injectable peptide therapy that acts on both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptors, It is designed to support metabolic regulation by helping influence appetite, insulin response, and blood sugar control.